Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A9 | P48067 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3850161 | 0.89 | SLC6A9 (1.00) | SLC6A9 | |
| SCHEMBL13714025 | 0.83 | SLC6A9 (0.90) | SLC6A9 | |
| SCHEMBL3848851 | 0.80 | SLC6A9 (0.71) | SLC6A9 | |
| SCHEMBL3848705 | 0.80 | SLC6A9 (0.90) | SLC6A9 | |
| SCHEMBL1689569 | 0.79 | SLC6A9 (0.75) | SLC6A9 | |
| SCHEMBL5584896 | 0.76 | SLC6A9 (0.70) | SLC6A9 | |
| SCHEMBL14836494 | 0.76 | SLC6A9 (0.70) | SLC6A9 | |
| SCHEMBL3853282 | 0.76 | SLC6A9 (0.77) | SLC6A9 | |
| SCHEMBL3848872 | 0.76 | SLC6A9 (0.61) | SLC6A9 | |
| SCHEMBL14836692 | 0.76 | SLC6A9 (0.80) | SLC6A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7576083-B2 | Morpholinyl piperidine glycine transporter inhibitors | MERCK & CO., INC. (US) | 2009-08-18 | — | — | US | disclosed |
| US-7576083-B2 | Morpholinyl piperidine glycine transporter inhibitors | MERCK & CO., INC. (US) | 2009-08-18 | — | — | US | disclosed |
| US-7576083-B2 | Morpholinyl piperidine glycine transporter inhibitors | MERCK & CO., INC. (US) | 2009-08-18 | — | — | US | disclosed |
| US-20070249606-A1 | Morpholinyl Piperidine Glycine Transporter Inhibitors | MERCK SHARP & DOHME CORP. | 2007-10-25 | — | — | US | disclosed |
| US-20070249606-A1 | Morpholinyl Piperidine Glycine Transporter Inhibitors | MERCK SHARP & DOHME CORP. | 2007-10-25 | — | — | US | disclosed |
| US-20070249606-A1 | Morpholinyl Piperidine Glycine Transporter Inhibitors | MERCK SHARP & DOHME CORP. | 2007-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070249606-A1 | Morpholinyl Piperidine Glycine Transporter Inhibitors | SLC1A1, SLC1A2, SLC6A7 | SLC6A9 30/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.